Chargement en cours...
DNA methylation of Hugl‐2 is a prognostic biomarker in kidney renal clear cell carcinoma
It has been reported that loss of Hugl‐2 contributes to tumour formation and progression in vitro and in vivo. However, whether Hugl‐2 levels decrease during kidney renal clear cell carcinoma (KIRC) and the mechanism involved remain unknown. This study aimed to investigate whether DNA methylation of...
Enregistré dans:
| Publié dans: | Clin Exp Pharmacol Physiol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821335/ https://ncbi.nlm.nih.gov/pubmed/32754907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1440-1681.13390 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|